Skip to Main Content
S. Karger AG
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 134, Issue 1
June 2015
Issue Cover
All Issues
ISSN 0001-5792
EISSN 1421-9662

Acta Haematologica 2015, Vol. 134, No. 1

Original Paper

Clinical Features and Survival of Asian Pediatric Patients with Paroxysmal Nocturnal Hemoglobinuria: Results from a Single Center in China
Subject Area: Hematology , Oncology
Meili Ge; Jun Shi; Xingxin Li; Yingqi Shao; Jinbo Huang; Zhendong Huang; Jing Zhang; Neng Nie; Yizhou Zheng
Acta Haematol (2015) 134 (1): 1–6. https://doi.org/10.1159/000369773
View articletitled, Clinical Features and Survival of Asian Pediatric Patients with Paroxysmal Nocturnal Hemoglobinuria: Results from a Single Center in China
Open the PDF for in another window
Risk Stratification Model in Elderly Patients with Multiple Myeloma: Clinical Role of Magnetic Resonance Imaging Combined with International Staging System and Cytogenetic Abnormalities
Subject Area: Hematology , Oncology
Moo-Kon Song; Joo-Seop Chung; Je-Jung Lee; Jae-Hoon Lee; Ik-Chan Song; Sang-Min Lee; Dong-Yeop Shin; Gyeong-Won Lee; In-Sook Lee
Acta Haematol (2015) 134 (1): 7–16. https://doi.org/10.1159/000370235
View articletitled, Risk Stratification Model in Elderly Patients with Multiple Myeloma: Clinical Role of Magnetic Resonance Imaging Combined with International Staging System and Cytogenetic Abnormalities
Open the PDF for in another window
Autophagic Markers BECLIN 1 and LC3 Are Associated with Prognosis of Multiple Myeloma
Subject Area: Hematology , Oncology
Geunyoung Jung; Jin Roh; Hyangsin Lee; Minchan Gil; Doc Hyun Yoon; Cheolwon Suh; Seongsoo Jang; Chan-Jeoung Park; Jooryung Huh; Chan-Sik Park
Acta Haematol (2015) 134 (1): 17–24. https://doi.org/10.1159/000368848
View articletitled, Autophagic Markers BECLIN 1 and LC3 Are Associated with Prognosis of Multiple Myeloma
Open the PDF for in another window
Measurement of Proteasome Activity in Peripheral Blood Mononuclear Cells as an Indicator of Susceptibility to Bortezomib-Induced Severe Neurological Adverse Events in Patients with Multiple Myeloma
Subject Area: Hematology , Oncology
Yukiko Cho; Mitsuo Hori; Yasushi Okoshi; Fumie Fujisawa; Atsushi Shinagawa; Daisuke Kudo; Takuya Komeno; Chikashi Yoshida; Yukitaka Katsura; Ikuyo Ota; Seiichi Shimizu; Masaharu Kamoshita; Katsuhiro Sasaki; Keiji Tanaka; Harumi Y. Mukai; Hiroshi Kojima; Ibaraki Hematology Oncology Palliation Expert Party (IB-HOPE)
Acta Haematol (2015) 134 (1): 25–31. https://doi.org/10.1159/000369445
View articletitled, Measurement of Proteasome Activity in Peripheral Blood Mononuclear Cells as an Indicator of Susceptibility to Bortezomib-Induced Severe Neurological Adverse Events in Patients with Multiple Myeloma
Open the PDF for in another window
Rebound Thrombocytosis following Induction Chemotherapy Is an Independent Predictor of a Good Prognosis in Acute Myeloid Leukemia Patients Attaining First Complete Remission
Subject Area: Hematology , Oncology
Umit Yavuz Malkan; Gursel Gunes; Ayse Isik; Eylem Eliacik; Sezgin Etgul; Tuncay Aslan; Muruvvet Seda Balaban; Ibrahim Celalettin Haznedaroglu; Haluk Demiroglu; Hakan Goker; Osman Ilhami Ozcebe; Nilgun Sayınalp; Salih Aksu; Yahya Buyukasik
Acta Haematol (2015) 134 (1): 32–37. https://doi.org/10.1159/000369917
View articletitled, Rebound Thrombocytosis following Induction Chemotherapy Is an Independent Predictor of a Good Prognosis in Acute Myeloid Leukemia Patients Attaining First Complete Remission
Open the PDF for in another window

Editorial Comment

Azacitidine and Allogeneic Stem Cell Transplantation: When and Why?
Subject Area: Hematology , Oncology
Basem M. William
Acta Haematol (2015) 134 (1): 38–39. https://doi.org/10.1159/000369243
View articletitled, Azacitidine and Allogeneic Stem Cell Transplantation: When and Why?
Open the PDF for in another window

Original Paper

Azacitidine Pre-Treatment Followed by Reduced-Intensity Stem Cell Transplantation in Patients with Higher-Risk Myelodysplastic Syndrome
Subject Area: Hematology , Oncology
Jae-Sook Ahn; Yeo-Kyeoung Kim; Yoo Hong Min; June-Won Cheong; Jun Ho Jang; Chul Won Jung; In Ho Kim; Hwi-Joong Yoon; Hong Ghi Lee; Sang Kyun Sohn; Joon Ho Moon; Hawk Kim; Yoo-Jin Kim; Jong-Ho Won; Joo-Seop Chung; Yeung Chul Mun; Je-Hwan Lee; Hyeoung-Joon Kim; The Korean Society of Hematology AML/MDS Working Party
Acta Haematol (2015) 134 (1): 40–48. https://doi.org/10.1159/000368711
View articletitled, Azacitidine Pre-Treatment Followed by Reduced-Intensity Stem Cell Transplantation in Patients with Higher-Risk Myelodysplastic Syndrome
Open the PDF for in another window
The Effect of Sphingosine 1-Phosphate/Sphingosine 1-Phosphate Receptor on Neutrophil Function and the Relevant Signaling Pathway
Subject Area: Hematology , Oncology
Zhongying Wang; Huahua Fan; Rufeng Xie; Jie Yang; Yana Ren; Yiming Yang; Wei Li
Acta Haematol (2015) 134 (1): 49–56. https://doi.org/10.1159/000369291
View articletitled, The Effect of Sphingosine 1-Phosphate/Sphingosine 1-Phosphate Receptor on Neutrophil Function and the Relevant Signaling Pathway
Open the PDF for in another window

Editorial Comment

The Importance of Body Surface Area at Baseline and during Treatment in Chronic Myeloid Leukemia Patients Treated with Imatinib
Subject Area: Hematology , Oncology
Massimo Breccia; Matteo Molica; Gioia Colafigli; Giuliana Alimena
Acta Haematol (2015) 134 (1): 57–58. https://doi.org/10.1159/000370098
View articletitled, The Importance of Body Surface Area at Baseline and during Treatment in Chronic Myeloid Leukemia Patients Treated with Imatinib
Open the PDF for in another window

Original Paper

Imatinib Mesylate Dose Adjustment Based on Body Surface Area for CML Chronic Phase Patients Intolerant to Standard Dosage
Subject Area: Hematology , Oncology
Hwa Jung Sung; Se Ryeon Lee; In Keun Choi; Yong Park; Chul Won Choi; Hyeoung-Joon Kim; Ho-Young Yhim; Byung Soo Kim
Acta Haematol (2015) 134 (1): 59–68. https://doi.org/10.1159/000369444
View articletitled, Imatinib Mesylate Dose Adjustment Based on Body Surface Area for CML Chronic Phase Patients Intolerant to Standard Dosage
Open the PDF for in another window
Real-world impact of routine addition of anti-thymocyte globulin to standard GVHD prophylaxis in myeloablative unrelated donor transplants: important gains in graft vs host disease prevention though no difference in overall survival
Prognostic value of the pretransplant fibrosis-4 (FIB-4) index on nonrelapse and overall mortality following unrelated single-unit cord blood transplantation in adults
Outcomes of Patients with Myeloid Malignancies and Cardiovascular Disease Undergoing Allogeneic Stem Cell Transplantation
Disseminated Mucormycosis and T-cell Depleted Allogeneic Stem Cell Transplantation - an unusual case study
  • Online ISSN 1421-9662
  • Print ISSN 0001-5792
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal